XML 25 R13.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP Shares [Member]
Noncontrolling Interests
The Dow Chemical Company [Domain]
The Dow Chemical Company [Domain]
Common Stock [Member]
The Dow Chemical Company [Domain]
Additional Paid-in Capital [Member]
The Dow Chemical Company [Domain]
Retained Earnings [Member]
The Dow Chemical Company [Domain]
Accumulated Other Comprehensive Loss
The Dow Chemical Company [Domain]
Unearned ESOP Shares [Member]
The Dow Chemical Company [Domain]
Noncontrolling Interests
Total Equity, Beginning at Dec. 31, 2017   $ 0 $ 6,553 $ 33,742 $ (8,591) $ (189)       $ 6,553 $ 33,742 $ (8,591) $ (189)  
Stock Issued                   0        
Stock-based compensation and allocation of ESOP shares     223     44       223     44  
Adjustments to Additional Paid in Capital, Other                   0        
Stock Issued During Period, Value, Parent Company Stock - DWDP     85             85        
Net income available for The Dow Chemical Company common stockholder       2,737             2,737      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       (2,110)             2,110      
Transfer of Business Under Common Control $ 215     (152) 0   $ 0 $ (215)     (152) 0    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       989 (1,037)           989 (1,037)    
Other     0 14             (14)      
Other comprehensive income 241       241     241       241    
Total Equity, Ending at Jun. 30, 2018 33,673 0 6,861 35,192 (9,387) (145)   33,673 $ 0 6,861 35,192 (9,387) (145) $ 1,152
Total Equity, Beginning at Mar. 31, 2018   0 6,758 33,899 (8,088) (150)       6,758 33,899 (8,088) (150)  
Stock Issued                   0        
Stock-based compensation and allocation of ESOP shares     81     5       81     5  
Adjustments to Additional Paid in Capital, Other                   0        
Stock Issued During Period, Value, Parent Company Stock - DWDP     22             22        
Net income available for The Dow Chemical Company common stockholder       1,333             1,333      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       (1,053)             1,053      
Transfer of Business Under Common Control       (37) 0   0       (37) 0    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       1,057 (1,057)           1,057 (1,057)    
Other     0 7             (7)      
Other comprehensive income (242)       (242)     (242)       (242)    
Total Equity, Ending at Jun. 30, 2018 33,673 0 6,861 35,192 (9,387) (145)   33,673 0 6,861 35,192 (9,387) (145) 1,152
The Dow Chemical Company’s stockholders’ equity 32,521             32,521            
The Dow Chemical Company’s stockholders’ equity 32,483             32,483            
Total Equity, Beginning at Dec. 31, 2018 33,621 0 7,042 35,460 (9,885) (134)   33,621   7,042 35,460 (9,885) (134)  
Stock Issued                   6        
Stock-based compensation and allocation of ESOP shares     147     35       147     35  
Adjustments to Additional Paid in Capital, Other                   (31)        
Stock Issued During Period, Value, Parent Company Stock - DWDP     28             28        
Net income available for The Dow Chemical Company common stockholder       631             758      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       (535)             535      
Transfer of Business Under Common Control (1,963)     (14,811) (793)   (353) (61)     (15,990) (793)    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       (111) 0           (111) 0    
Other     30 7             (7)      
Other comprehensive income 104       104     104       104    
Total Equity, Ending at Jun. 30, 2019 18,500 7 7,186 20,110 (8,988) (99)   18,269 0 7,192 19,575 (8,988) (99) 589
Total Equity, Beginning at Mar. 31, 2019   0 7,153 35,403 (9,783) (105)       7,153 35,403 (9,783) (105)  
Stock Issued                   6        
Stock-based compensation and allocation of ESOP shares     64     6       64     6  
Adjustments to Additional Paid in Capital, Other                   (31)        
Stock Issued During Period, Value, Parent Company Stock - DWDP     0             0        
Net income available for The Dow Chemical Company common stockholder       75             202      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       0             0      
Transfer of Business Under Common Control       (14,846) (793)   $ (353)       (16,025) (793)    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification       0 0           0 0    
Other     30 5             (5)      
Other comprehensive income 2       2     2       2    
Total Equity, Ending at Jun. 30, 2019 18,500 $ 7 $ 7,186 $ 20,110 $ (8,988) $ (99)   18,269 $ 0 $ 7,192 $ 19,575 $ (8,988) $ (99) $ 589
The Dow Chemical Company’s stockholders’ equity $ 17,911             $ 17,680